Tags: gabapentinotolaryngologyburning mouth syndromeepistaxishereditary hemorrhagic telangiectasia
Profile | Contacts | Recent Articles on Subject | |
---|---|---|---|
1 | Kristen Monaco MedPage Today | ||
2 | Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. | ||
3 | Judy George MedPage Today Medical reporter, writer. | Continuous Parkinson's Disease Therapy Wins FDA Nod - 28 days ago Novel Agent Reduces Monthly Migraine Days - 2 months ago ALS Therapy to Be Pulled From the Market, Drugmaker Says - 7 months ago | |
4 | Elaine Chen STAT News Reporter at STATnews. Formerly at Business Insider. Chicago, Illinois | More evidence on GLP-1s and opioid addiction - 29 days ago | |
5 | Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA | ||
6 | James Woodford New Scientist Ocean Correspondent. South Coast, New South Wales | Rapamycin could make an epilepsy drug much safer during pregnancy - about 1 month ago | |
7 | John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California | IRLAB’s new drug shows promise in treating apathy in Parkinson’s patients - about 1 month ago | |
8 | David Nield Science Alert Freelance tech, science writer. Marple, Manchester, UK | ||
9 | Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland | FDA Expands Label for Bempedoic Acid to Reduce Cardiovascular Risk, With or Without Statins - 8 months ago Investigational GLP-1 Medication Found to Reduce Body Weight - 9 months ago Prevention, Treatment for Migraine Rapidly Evolves, Calling for Development of Novel Drugs - 12 months ago | |
10 | Meagan Parrish Pharma Voice Senior editor @industrydive.
Pharma world follower. Wisconsin, USA |